Evergen (formerly TissX LLC) focuses on advanced biotechnological solutions aimed at improving health outcomes through innovative therapies. The company specializes in the development of regenerative medicine products that utilize proprietary technologies to harness the body's natural healing processes. Their pipeline includes a range of therapies designed to address various medical conditions, emphasizing the importance of tissue engineering and cellular therapies in promoting recovery and regeneration.

The technologies employed by Evergen are centered around the manipulation of biological materials and cellular systems to create effective treatment options. This includes the use of biomaterials that support cell growth and differentiation, as well as advanced delivery systems that enhance the efficacy of therapeutic agents. By integrating cutting-edge scientific research with practical applications, Evergen aims to revolutionize the field of regenerative medicine and provide patients with innovative solutions for healing and recovery.

United States

Tissx sources, manufactures and supplies tissue products and services for cardiac, vascular and other specialty surgeries. Our goal is to make affordable high quality tissue products available worldwide. We develop and manufacture products including fixed pericardial tissue patches and valve repair products. Tissx also works with corporations to source and supply tissue, provide OEM services and develop tissue bioprosthetics.

Evergen (formerly TissX LLC)

Company Details